Liothyronine Sodium Tablet
Product Images NDC 68071-3571

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 68071-3571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3571 9)

The label for Liothyronine Sodium 5 mcg oral tablets from NuCare Pharmaceuticals, Inc. The package contains 90 tablets, with NDC 68071-3571-9. The label includes manufacturing details by Sigmapharm Laboratories, LLC, and Bensalem, PA. It features warnings to keep out of reach of children and store at controlled temperature 59-86°F. Additional product codes and safety instructions are also present.*

FDA Label Image

Image Description (Structure)

Chemical structure diagram of Liothyronine Sodium showing two aromatic rings, an amino group, a carboxylate group bound to sodium, molecular formula C15H11I3NNaO4, and molecular weight 672.96.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.